To understand the digital health landscape in different countries from national strategy and regulation to HTA evaluation, adoption, and challenges. The objective is to use this information to better inform digital health policy in Thailand as well as to create a reference case to conduct HTA for digital health technologies.

This project aims to strengthened Thai health system post COVID times and has been started since 1 April 2022 until the end of March 2023. There are five sub-projects under the grant consisting of environmental health, local governance, health financing, and digital technology.post COVID

Digital Health,Health Information

The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve

This report summarizes the meeting on “Improving Priority Antibiotic Access in Thailand and Regional Coordinated Procurement Mechanisms,” held on 7–8 July 2025 in Bangkok, Thailand. The meeting was convened by the Health Intervention and Technology Assessment Program Foundation (HITAP), in collabora

Over the years, NICE’s guidance and methods have generated substantial interest from researchers, non-governmental organisations, health insurance funds and ministries of health and finance across the globe. NICE International was set up to respond to requests from around the world for help to impro

– The pharmaceutical industry is a significant emitter of carbon emissions, which accelerates climate change and directly affects human health and health systems. – The safety and efficacy profiles of intravenous (IV) and oral paracetamol for patients undergoing surgeries are comparable. – Swi

Apirujee Punjataewakupt, PhD, earned her doctoral degree in pharmaceutical sciences from Chulalongkorn University. She has diverse experience in both the pharmaceutical industry and health-related research. She is currently serving as a research assistant at the Health Intervention and Technology Assessment Program (HITAP).Her expertise includes ph

Phornnaphat is a licensed pharmacist with a diverse academic background, holding a bachelor\'s degree in pharmacy from Silpakorn University and a master’s degree in molecular biology from Nagoya University (MEXT Scholarship). With this interdisciplinary training, she specializes in applying data and evidence to inform health policy.Her research foc

Picharee Karunayawong is a researcher and economist at the Health Intervention and Technology Assessment Program Foundation (HITAP). Her work focuses on data-driven and quantitative research aimed at improving the efficiency of national health systems and reducing the use of low-value care. She works closely with the policymakers, participating in